Measles Research Today is a free monthly online journal that collates and summarizes the latest research about Measles, including details on german measles, symptoms, vaccine, treatment, rubella.

Volume 2 (2005), Issue 12 (December)

1. Impact of a decline in Colorado Medicaid managed care enrollment on access and quality of preventive primary care services.
   Pediatrics, 116(6): 1474-9. [Abstract] [Full-text]
2. A limited measles outbreak in a highly vaccinated US boarding school.
   Pediatrics, 116(6): 1287-91. [Abstract] [Full-text]
3. Protracted mumps encephalitis with good outcome.
   J Clin Neurosci, 12(8): 960-2. [Abstract] [Full-text]
4. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
   Arch Pediatr Adolesc Med, 159(12): 1136-44. [Abstract] [Full-text]
5. Malaria chemoprophylaxis and the serologic response to measles and diphtheria-tetanus-whole-cell pertussis vaccines.
   Malar J, 4: 53. [Abstract] [Full-text]
6. Alterations in cell-mediated immune response in subacute sclerosing panencephalitis.
   J Neuroimmunol, 170(1): 179-85. [Abstract] [Full-text]
7. Crude saponins improve the immune response to an oral plant-made measles vaccine.
   Vaccine, 24(2): 144-50. [Abstract] [Full-text]
8. Prevalence of childhood exanthematic disease antibodies in paramedical students: need of vaccination.
   Vaccine, 24(2): 171-6. [Abstract] [Full-text]
9. Immunogenicity of peptides of measles virus origin and influence of adjuvants.
   Vaccine, 24(2): 185-94. [Abstract] [Full-text]
10. Identification of Class II HLA-DRB103-Bound Measles Virus Peptides by 2D-Liquid Chromatography Tandem Mass Spectrometry.
    J Proteome Res, 4(6): 2243-9. [Abstract] [Full-text]
11. How do caregivers know when to take their child for immunizations?
    BMC Pediatr, 5: 44. [Abstract] [Full-text]
12. Immunologic significance of HLA class I genes in measles virus-specific IFN-gamma and IL-4 cytokine immune responses.
    Immunogenetics, 57(11): 828-36. [Abstract] [Full-text]
13. New viral vaccines.
    Virology, 344(1): 240-9. [Abstract] [Full-text]
14. Structural disorder within the replicative complex of measles virus: functional implications.
    Virology, 344(1): 94-110. [Abstract] [Full-text]
15. Immunisation status of children in Germany: temporal trends and regional differences.
    Eur J Pediatr, 165(1): 30-6. [Abstract] [Full-text]
16. Immunosuppression caused by measles virus: role of viral proteins.
    Rev Med Virol, 16(1): 49-63. [Abstract] [Full-text]
17. Review of the temporal and geographical distribution of measles virus genotypes in the prevaccine and postvaccine eras.
    Virol J, 2: 87. [Abstract] [Full-text]
18. Young children non-immunized against measles: Characteristics and programmatic implications.
    Acta Paediatr, 95(1): 44-9. [Abstract] [Full-text]
19. Lymphoproliferative disorders: prospects for gene therapy.
    Pathology, 37(6): 523-33. [Abstract] [Full-text]
20. Morbilliviruses and human disease.
    J Pathol, 208(2): 199-214. [Abstract] [Full-text]
21. Immunization coverage among Hispanic ancestry, 2003 national immunization survey.
    Am J Prev Med, 29(5): 421-7. [Abstract] [Full-text]
22. Immunization rates and timely administration in pre-school and school-aged children.
    Eur J Pediatr, 165(2): 124-9. [Abstract] [Full-text]

© 2004-2011 Measles Research Today. All Rights Reserved.